Clinical trial / 2020
Intragastric quinine reduced postprandial glucose and stimulated insulin and GLP-1 without altering gastric emptying or energy intake in healthy men.
In two study parts, healthy lean men received intragastric quinine (275 mg or 600 mg) or control 30 minutes before a mixed-nutrient drink (part A, n=15) or a buffet meal (part B, n=12). Alone, both doses modestly stimulated insulin (P < 0.05). Following the drink, both quinine doses reduced plasma glucose and stimulated insulin (P < 0.05); 275 mg stimulated GLP-1 (P < 0.05), while 600 mg showed a trend toward stimulating GLP-1 (P = 0.066) and glucagon (P = 0.073). Quinine did not alter gastric emptying of the nutrient drink or subsequent buffet energy intake.
- Study type
- Double-blind, randomized crossover trial
- Who was studied
- Healthy lean men aged 26 ± 2 years (part A: n=15, part B: n=12)
- What was measured
- Plasma glucose, insulin, GLP-1, glucagon, gastric emptying, and buffet meal energy intake
THE PAPER
Intragastric administration of the bitter tastant quinine lowers the glycemic response to a nutrient drink without slowing gastric emptying in healthy men.
Bitarafan V, Fitzgerald PCE, Little TJ, Meyerhof W, Jones KL, Wu T, Horowitz M, Feinle-Bisset C. Am J Physiol Regul Integr Comp Physiol, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.